Protected: trademark_similarity_notice Marcus Julius Zanon mjzanon

Skip to content

Brazil & LATAM IP Risk Intelligence for Foreign IP Law Firms
IP Compliance Intelligence
- Anvisa Publishes Guidance on Monitoring International Health Regulation (IHR)
- Brazil’s ANPD Sets the Regulatory Agenda
LATAM IP Market Entry Intelligence
Our Mission
Our IP Services
Brazil Pharma IP Threat Board 2026
International Desk
- CHINA
- USA
  - SINGAPORE
- JAPAN
Insights
About US
Contact us

Protected: trademark_similarity_notice

This content is password-protected. To view it, please enter the password below.

Password:

Historic milestone: Brazil and the European Union achieve mutual adequacy in data protection
What the Ozempic® and Rybelsus® decision really means for pharma strategy in 2026
Brazil Establishes a Fully Regulated Cannabis Medicinal Framework — Strategic Implications for IP, Compliance and Market Entry
(no title)
Brazil’s Health Authority Publishes Guidance on Monitoring International Health Regulation (IHR) Core Capacities at Designated Points of Entry

Brazil IP counsel for foreign law firms, agents and in-house teams.